Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP240180.RAc0AUIQkhW70R2X9pIS8wd5rgtGFRITt8uvyca6O9N8o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP240180.RAc0AUIQkhW70R2X9pIS8wd5rgtGFRITt8uvyca6O9N8o130_assertion type Assertion NP240180.RAc0AUIQkhW70R2X9pIS8wd5rgtGFRITt8uvyca6O9N8o130_head.
- NP240180.RAc0AUIQkhW70R2X9pIS8wd5rgtGFRITt8uvyca6O9N8o130_assertion description "[Importantly, it also indicates that it is crucial to evaluate the levels of Apaf-1 and XIAP proteins in patient samples before using Smac peptide therapy in the treatment of human leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP240180.RAc0AUIQkhW70R2X9pIS8wd5rgtGFRITt8uvyca6O9N8o130_provenance.
- NP240180.RAc0AUIQkhW70R2X9pIS8wd5rgtGFRITt8uvyca6O9N8o130_assertion evidence source_evidence_literature NP240180.RAc0AUIQkhW70R2X9pIS8wd5rgtGFRITt8uvyca6O9N8o130_provenance.
- NP240180.RAc0AUIQkhW70R2X9pIS8wd5rgtGFRITt8uvyca6O9N8o130_assertion SIO_000772 12642862 NP240180.RAc0AUIQkhW70R2X9pIS8wd5rgtGFRITt8uvyca6O9N8o130_provenance.
- NP240180.RAc0AUIQkhW70R2X9pIS8wd5rgtGFRITt8uvyca6O9N8o130_assertion wasDerivedFrom befree-20150227 NP240180.RAc0AUIQkhW70R2X9pIS8wd5rgtGFRITt8uvyca6O9N8o130_provenance.
- NP240180.RAc0AUIQkhW70R2X9pIS8wd5rgtGFRITt8uvyca6O9N8o130_assertion wasGeneratedBy ECO_0000203 NP240180.RAc0AUIQkhW70R2X9pIS8wd5rgtGFRITt8uvyca6O9N8o130_provenance.